Dahlmann-Noor, Annegret H. https://orcid.org/0000-0002-7402-4350
Bokre, Desta
Khazova, Marina
Price, Luke L. A.
Article History
Received: 8 September 2024
Revised: 4 December 2024
Accepted: 12 December 2024
First Online: 22 January 2025
Declarations
:
: This article does not contain any studies with human participants performed by any of the authors.
: Informed consent was not required, as there were no human participants.
: Author A Dahlmann-Noor has received advisory fees from Santen, SightGlass Vision, Novartis, Thea, CooperVision, has prepared educational activities and material for Santen, CooperVision, Zeiss and Bayer, and has contributed to parent focus groups for Novartis; she is/was principal and/or co-ordinating investigator on myopia management trials (CHAMP, CHAMP-UK, OCUMENSION, MYOPIA-X, MODERATO). The other authors have no interests to declare.